Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.
about
BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectinThe Western progression of lyme disease: infectious and Nonclonal Borrelia burgdorferi Sensu Lato populations in Grand Forks County, North Dakota.Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins.The Borrelia burgdorferi CheY3 response regulator is essential for chemotaxis and completion of its natural infection cycle.Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine.
P2860
Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evaluation of RevA, a fibronec ...... ne candidate for lyme disease.
@en
type
label
Evaluation of RevA, a fibronec ...... ne candidate for lyme disease.
@en
prefLabel
Evaluation of RevA, a fibronec ...... ne candidate for lyme disease.
@en
P2093
P2860
P356
P1476
Evaluation of RevA, a fibronec ...... ne candidate for lyme disease.
@en
P2093
Angela M Floden
Catherine A Brissette
Robert A Gaultney
Tammy Gonzalez
P2860
P304
P356
10.1128/CVI.00758-12
P577
2013-04-17T00:00:00Z